Jump to content
RemedySpot.com

Clinical trials ~ smoke and mirrors?

Rate this topic


Recommended Posts

Posted

Some trials don't want a full cross section of CLL patients, but select out

younger, fitter patients with no comorbidities. The CLL8 trial is a case in

point.

In other comparative drug trials, the 'new' drug is often compared to an old

drug.

In CLL chlorambucil is often this comparator and it has been in the past

administered at less than optimum dosages. This skews the trial in the favour of

the new drug being successful.

I think that if public money is being pumped into these trials (how many are

funded), that the investigators should be required to publish the results, good

or bad. Currently, if the trial is terminated and the results never published.

Also the data from the trials should be placed in the public domain, for others

to use should they wish to.

The FCR + Lumiliximab (LUCID) trials was terminated last August and perhaps I

have missed it, but I never saw much published. The only paper to come to light

is by Dr. J. Byrd with a commentary by T. Robak.

But in North America the writing is on the wall... if we don't start using

clinical trials they are going off shore to countries were there is less expense

and a greater demand.

People have commented to me that it will never happen in CLL because of

differences in the ethnicity, but I remind them that Hungary, Poland, Belarus,

Lithuania, Russia, and the Ukraine is full of CLL patients with Ashkenazi Jewish

heritage, one of the major ethnic groups inflicted with CLL.

http://www.nature.com/leu/journal/v12/n10/abs/2401140a.html

~chris

Posted

Regarding participation rates here versus abroad, here in the States, if your

treating doc is not investigator or a member of a cooperative group, a referral

to a trial is rare.

" Many cancer patients live far from treatment centers, and many health insurers

do not pay for experimental therapies—barriers that don't exist in the United

Kingdom. Moreover, all U.K. oncologists belong to the cancer network. By

contrast, collaborative groups in the United States require membership, and not

all oncologists are members. "

http://jnci.oxfordjournals.org/content/99/6/420.full

Off label use of drugs approved for another indication is also a barrier to

trial participation cited in this article.

Karl

>

> Some trials don't want a full cross section of CLL patients, but select out

> younger, fitter patients with no comorbidities. The CLL8 trial is a case in

point.

>

> In other comparative drug trials, the 'new' drug is often compared to an old

> drug.

>

> In CLL chlorambucil is often this comparator and it has been in the past

> administered at less than optimum dosages. This skews the trial in the favour

of

> the new drug being successful.

>

> I think that if public money is being pumped into these trials (how many are

> funded), that the investigators should be required to publish the results,

good

> or bad. Currently, if the trial is terminated and the results never published.

> Also the data from the trials should be placed in the public domain, for

others

> to use should they wish to.

>

> The FCR + Lumiliximab (LUCID) trials was terminated last August and perhaps I

> have missed it, but I never saw much published. The only paper to come to

light

> is by Dr. J. Byrd with a commentary by T. Robak.

>

> But in North America the writing is on the wall... if we don't start using

> clinical trials they are going off shore to countries were there is less

expense

> and a greater demand.

>

> People have commented to me that it will never happen in CLL because of

> differences in the ethnicity, but I remind them that Hungary, Poland, Belarus,

> Lithuania, Russia, and the Ukraine is full of CLL patients with Ashkenazi

Jewish

> heritage, one of the major ethnic groups inflicted with CLL.

>

> http://www.nature.com/leu/journal/v12/n10/abs/2401140a.html

>

> ~chris

>

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...